Literature DB >> 20085748

Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase.

Ming-Qing Dong1, Hai-Ying Sun, Qiang Tang, Hung-Fat Tse, Chu-Pak Lau, Gui-Rong Li.   

Abstract

The aim of the present study was to investigate whether/how the recombinant human cardiac I(Ks) could be regulated by epidermal growth factor receptor kinase in HEK 293 cells stably expressing hKCNQ1/hKCNE1 genes using the approaches of perforated patch clamp technique, immunoprecipitation and Western blot analysis. It was found that the broad spectrum isoflavone tyrosine kinase inhibitor genistein and the selective epidermal growth factor receptor kinase inhibitor tyrphostin AG556 suppressed the recombinant I(Ks), and their inhibition was countered by the protein tyrosine phosphatase inhibitor orthovanadate. The Src-family kinase inhibitor PP2 reduced the current, but the effect was not antagonized by orthovanadate. Immunoprecipitation and Western blot analysis revealed that tyrosine phosphorylation level of hKCNQ1 protein was decreased by genistein or AG556, but not by PP2. These results provide the novel information that epidermal growth factor receptor kinase, but not Src-family kinases, regulates the recombinant cardiac I(Ks) stably expressed in HEK 293 cells via phosphorylating KCNQ1 protein of the channel. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085748     DOI: 10.1016/j.bbamem.2010.01.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  The life and death of breast cancer cells: proposing a role for the effects of phytoestrogens on potassium channels.

Authors:  Joanne L Wallace; Iain F Gow; Mary Warnock
Journal:  J Membr Biol       Date:  2011-07-05       Impact factor: 1.843

2.  Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Wei Wu; Hai-Ying Sun; Yan Wang; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2017-02-09       Impact factor: 8.739

3.  Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium K(IR)2.3 channel, stably expressed in HEK 293 cells.

Authors:  De-Yong Zhang; Yan-Hui Zhang; Hai-Ying Sun; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells.

Authors:  Xiao-Hui Xu; Hai-Ying Sun; Yan-Hui Zhang; Wei Wu; Kui-Hao Chen; Yi Liu; Chun-Yu Deng; Xi-Yong Yu; Man-Wen Jin; Gui-Rong Li
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  The KCNE Tango - How KCNE1 Interacts with Kv7.1.

Authors:  Eva Wrobel; Daniel Tapken; Guiscard Seebohm
Journal:  Front Pharmacol       Date:  2012-08-02       Impact factor: 5.810

6.  Apamin does not inhibit human cardiac Na+ current, L-type Ca2+ current or other major K+ currents.

Authors:  Chih-Chieh Yu; Tomohiko Ai; James N Weiss; Peng-Sheng Chen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

7.  Effects of equol on multiple K+ channels stably expressed in HEK 293 cells.

Authors:  Xiu-Ling Deng; Yan Wang; Guo-Sheng Xiao
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

8.  Tyrphostin AG556 increases the activity of large conductance Ca2+ -activated K+ channels by inhibiting epidermal growth factor receptor tyrosine kinase.

Authors:  Yan Wang; Hai-Ying Sun; Ying-Guang Liu; Zheng Song; Gang She; Guo-Sheng Xiao; Yan Wang; Gui-Rong Li; Xiu-Ling Deng
Journal:  J Cell Mol Med       Date:  2017-03-14       Impact factor: 5.310

9.  The mineralocorticoid receptor leads to increased expression of EGFR and T-type calcium channels that support HL-1 cell hypertrophy.

Authors:  Katharina Stroedecke; Sandra Meinel; Fritz Markwardt; Udo Kloeckner; Nicole Straetz; Katja Quarch; Barbara Schreier; Michael Kopf; Michael Gekle; Claudia Grossmann
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.